Not Signed In - [ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
Peginterferon alfa-2a |
Pegasys |
Image:PEGASYS.png PEGASYS Systematic (IUPAC) name ? Identifiers CAS number 215647-85-1 ATC code L03AB11 PubChem ? Chemical data Formula ? Mol. weight ? Pharmacokinetic data Bioavailability ? Metabolism ? Half life ? Excretion ? Therapeutic considerations Pregnancy cat. ? Legal status ? Routes ? Pegylated interferon alfa 2a (40KD) (commercial name PEGASYS) is an antiviral drug discovered at t ...
Wikipedia - [full article]
Peginterferon alfa-2a Clinical Trials
- Thymosin Plus PEG-Interferon in Non-Cirrhotic Hepatitis C Patients Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00040027 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- Long Term Interferon for Patients Who Did Not Clear Hepatitis C Virus with Standard Treatment
ClinicalTrials.gov Identifier: NCT00006164 - Active, not recruiting
Chronic Hepatitis C; Cirrhosis, Liver; Fibrosis, Liver; Hepatic Cirrhosis
- A Study of Peginterferon Alfa-2a in Combination with Ribavirin in Patients with Chronic Hepatitis C.
ClinicalTrials.gov Identifier: NCT00144469 - Completed
Chronic Hepatitis C
- Pegylated Interferon Alfa-2a Maintenance Therapy and Liver Disease Progression in People Infected With Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00078403 - Active, not recruiting
HIV Infections; Hepatitis C; Liver Disease
- Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/Hepatitis B Co-Infection and Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00154869 - Recruiting
Patients with dual chronic hepatitis B and C
- Multicenter Study Evaluating 12 Versus 24 Weeks Therapy with Peginterferon and Ribavirin for HCV Genotype 2 or 3
ClinicalTrials.gov Identifier: NCT00143000 - Recruiting
Hepatitis C Virus
- Low-Dose Peginterferon and Ribavirin to Treat Chronic Hepatitis C in Patients Infected with HCV Genotype 2 or 3
ClinicalTrials.gov Identifier: NCT00056862 - Recruiting
Hepatitis C
- Randomized Trial of 24 or 48 Weeks of Peginterferon Alfa-2a Plus Ribavirin for HCV Genotype 1-Infected Patients
ClinicalTrials.gov Identifier: NCT00495131 - Recruiting
Chronic Hepatitis C
- Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin for the Treatment of Hepatitis C
ClinicalTrials.gov Identifier: NCT00495391 - Recruiting
Chronic Hepatitis C
- A Study of Induction Dosing With PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus in Treatment-Naive Patients With Chronic Hepatitis C.
ClinicalTrials.gov Identifier: NCT00394277 - Active, not recruiting
Hepatitis C, Chronic
- Peginterferon Alfa-2a and Ribavirin for Genotype 2 Chronic Hepatitis C: Duration and Ribavirin Dose Stratified by RVR
ClinicalTrials.gov Identifier: NCT00532701 - Recruiting
Chronic Hepatitis C; Genotype 2; Peginterferon; Ribavirin
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-Infection.
ClinicalTrials.gov Identifier: NCT00353418 - Active, not recruiting
Hepatitis C, Chronic
- A Comparison of the Effectiveness, Safety, and Tolerability of Two Different Hepatitis C Treatments in Patients Infected with Both HIV and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00008463 - Completed
HIV Infections; Hepatitis C
- Peginterferon Alfa-2a, Ribavirin, Amantadine/Placebo in HCV-Genotype-1-Infection (PRAMA)
ClinicalTrials.gov Identifier: NCT00127777 - Active, not recruiting
Hepatitis C, Chronic
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Positive Chronic Hepatitis B (CHB).
ClinicalTrials.gov Identifier: NCT00435825 - Recruiting
Hepatitis B, Chronic
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg-Positive Chronic Hepatitis B (CHB).
ClinicalTrials.gov Identifier: NCT00436163 - Recruiting
Hepatitis B, Chronic
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.
ClinicalTrials.gov Identifier: NCT00460850 - Recruiting
Hepatitis B, Chronic
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.
ClinicalTrials.gov Identifier: NCT00487747 - Recruiting
Hepatitis B, Chronic
- Long-term Peginterferon alpha-2a Plus Ribavirin to Treat Chronic Hepatitis C in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00076765 - Recruiting
Hepatitis C; HIV Infections
- Peginterferon Alfa-2a Plus Ribavirin and Epoetin β in HIV-Infected Patients Coinfected With Hepatitis C Virus Not Responding to Previous Treatment Regimens
ClinicalTrials.gov Identifier: NCT00470210 - Recruiting
Hepatitis C; HIV Infections
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.
ClinicalTrials.gov Identifier: NCT00474955 - Recruiting
Hepatitis C, Chronic
- A Safety and Efficacy Study of Prophylactically Administered Pegylated Interferon alfa-2a (Pegasys) plus Ribavirin vs. No Prophylaxis Following Liver Transplantation for Hepatitis C
ClinicalTrials.gov Identifier: NCT00087633 - Active, not recruiting
Hepatitis C
- SYREN Study: A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Non-Responder Patients With Chronic Hepatitis C (CHC) Genotype 1.
ClinicalTrials.gov Identifier: NCT00412334 - Recruiting
Hepatitis C, Chronic
- Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-Viral Treatment
ClinicalTrials.gov Identifier: NCT00226382 - Recruiting
Chronic Hepatitis B
- SOFIA-LTT Study: A Study of Intermittent Long Term Treatment With PEGASYS® (Peginterferon Alfa-2a (40KD)) in Patients With HBeAg Negative Chronic Hepatitis B (CHB).
ClinicalTrials.gov Identifier: NCT00442572 - Recruiting
Hepatitis B, Chronic
- Safety and Tolerability of Pegylated Interferon (PEG-IFN) Alfa-2a in HIV Infected People
ClinicalTrials.gov Identifier: NCT00078442 - Active, not recruiting
HIV Infections
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus COPEGUS® (Ribavirin) With or Without Pioglitazone in Treatment-Naive Patients With Chronic Hepatitis C and Insulin Resistance.
ClinicalTrials.gov Identifier: NCT00545233 - Not yet recruiting
Hepatitis C, Chronic
- Thymosin Plus PEG-Interferon in Hepatitis C Patients with Cirrhosis Who Did Not Respond to Interferon or Interferon Plus Ribavirin
ClinicalTrials.gov Identifier: NCT00039962 - Active, not recruiting
Hepatitis C; Hepatitis C, Chronic
- A Study of Peginterferon Alfa-2a in Combination With Ribavirin in Chronic Hepatitis C (CHC) Patients With Compensated Liver Cirrhosis (LC)
ClinicalTrials.gov Identifier: NCT00304551 - Recruiting
Liver Cirrhosis; Chronic Hepatitis C
- IMPROVE Study(The Individualized Management With PEGASYS and Ribavirin Offering Viral Eradication): A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Copegus (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Non-Genotype 2/3.
ClinicalTrials.gov Identifier: NCT00483938 - Recruiting
Hepatitis C, Chronic
- Peginterferon Alfa-2a Plus Ribavirin Plus Amantadine for the Treatment of Hepatitis C Infected Patients
ClinicalTrials.gov Identifier: NCT00221624 - Completed
HCV Infection; Hepatitis C, Chronic
- A Phase I Trial of Peginterferon alfa-2b (PEG-Intron) for Plexiform Neurofibromas
ClinicalTrials.gov Identifier: NCT00156754 - Recruiting
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared With Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients
ClinicalTrials.gov Identifier: NCT00402428 - Active, not recruiting
Chronic Hepatitis C
- Efficacy of Albumin Interferon Alfa-2b With Ribavirin Compared to Peg-IFN Alfa-2a With Ribavirin in IFN Naive Patients Geno2/3
ClinicalTrials.gov Identifier: NCT00411385 - Active, not recruiting
Chronic Hepatitis C
- A Study of PEGASYS® (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.
ClinicalTrials.gov Identifier: NCT00475072 - Completed
Hepatitis C, Chronic
- A Randomized Phase II Study of Two Doses of Interferon alfa-2a (IFN alfa-2a) in Combination With Zidovudine (AZT) and Dideoxycytidine (ddC) Versus AZT and ddC Only in Patients With HIV Infection and Less Than 400 CD4 Cells/mm3
ClinicalTrials.gov Identifier: NCT00000754 - Completed
HIV Infections
- 48 Weeks Combination Therapy for Patients with HBeAg-negative Chronic Hepatitis B Virus (HBV) Infection
ClinicalTrials.gov Identifier: NCT00114361 - Active, not recruiting
Hepatitis B
- Study to Evaluate Viral Kinetics in the First 12 Weeks of Patients With Hepatitis C Coinfected With HIV Treated With Induction Doses of Peginterferon Alpha-2a (40 KD) and Ribavirin With Epoetin β Support
ClinicalTrials.gov Identifier: NCT00356486 - Active, not recruiting
HIV Infections
- A Study of Debio 025 in Combination With Peginterferon Alpha-2a and Ribavirin in Chronic HCV Patients Non-Responders to Standard Treatment
ClinicalTrials.gov Identifier: NCT00537407 - Recruiting
Chronic Hepatitis C
- Zidovudine Levels in HIV Infected Patients Being Treated for HCV
ClinicalTrials.gov Identifier: NCT00059358 - Active, not recruiting
HIV Infections; Hepatitis C
- Pegylated Interferon to Treat Chronic Hepatitis D
ClinicalTrials.gov Identifier: NCT00023322 - Recruiting
Hepatitis D
- Peginterferon alpha-2a and ribavirin to treat hepatitis C in HIV-infected patients
ClinicalTrials.gov Identifier: NCT00085917 - Active, not recruiting
Hepatitis C; HIV Infections
- An Extension Study to Evaluate the Safety and Efficacy of Celgosivir and Peginterferon Alfa-2b, With or Without Ribavirin, in Patients With Chronic Hepatitis C Genotype 1 Infection
ClinicalTrials.gov Identifier: NCT00292084 - Active, not recruiting
Hepatitis C, Chronic
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00361179 - Completed
Coinfection With Hepatitis B Virus and Hepatitis C Virus; Monoinfection With Hepatitis C Virus
- Induction Dosing With Pegylated Interferon Alfa 2a and Ribavirin in Patients With Chronic Hepatitis C Genotype 1
ClinicalTrials.gov Identifier: NCT00192647 - Active, not recruiting
Chronic Hepatitis C
- Proteinase 3 PR1 Peptide Mixed With Montanide ISA-51 VG Adjuvant and Administered With GM-CSF and Peginterferon Alfa-2b [PEG-INTRON(R)]
ClinicalTrials.gov Identifier: NCT00415857 - Recruiting
Leukemia
- Low Dose Peginterferon-α 2a for Chronic Hepatitis C, Genotypes 2 or 3, in HIV-Coinfected Patients
ClinicalTrials.gov Identifier: NCT00553930 - Recruiting
Hepatitis C, Chronic; HIV Infections
- Safety, Tolerability, and Anti-HIV Activity of PEG-Intron in HIV-Positive Children
ClinicalTrials.gov Identifier: NCT00006325 - Active, not recruiting
HIV Infections
- Efficacy and Safety of 24 vs 48 Weeks of Pegetron® (Peginterferon Alfa-2b + Ribavirin) in Naïve Genotype 1 Hepatitis C (Study P05016)
ClinicalTrials.gov Identifier: NCT00423800 - Recruiting
Hepatitis C, Chronic
- HRN 004- Peginterferon a-2a Plus Ribavirin for Chronic Hepatitis C Infection in HIV Infected Persons Who Have Failed to Achieve a Sustained Virologic Response Following Previous Interferon Therapy
ClinicalTrials.gov Identifier: NCT00215839 - Active, not recruiting
Chronic Hepatitis C Infection in HIV Infected Persons; HIV Infections
- A Study to Evaluate the Safety, Antiviral Effect, and Pharmacokinetics of Celgosivir in Combination With Peginterferon Alfa-2b and Ribavirin in Treatment-Naïve Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00332176 - Recruiting
Chronic Hepatitis C
- Comparative Study of Pegasys plus Copegus in Treatment Naive Latino and Caucasian Patients with Chronic Hepatitis C, Genotype 1
ClinicalTrials.gov Identifier: NCT00107653 - Active, not recruiting
Hepatitis C
- Peg-Intron for Prevention of Disease Progress in Chronic Hepatitis C Patients with Cirrhosis
ClinicalTrials.gov Identifier: NCT00048724 - Active, not recruiting
Chronic Hepatitis C; Cirrhosis
- Pre-Transplant Treatment to Prevent Recurrence of Hepatitis C After Living Donor Liver Transplantation
ClinicalTrials.gov Identifier: NCT00135798 - Recruiting
Hepatitis C
- Gefitinib and PEG-Interferon Alfa-2a in Treating Patients With Unresectable or Metastatic Skin Cancer
ClinicalTrials.gov Identifier: NCT00423397 - Recruiting
Non-Melanomatous Skin Cancer
- A Phase I Study of AZT and Human Interferon Alpha (Recombinant Alpha-2A and Lymphoblastoid) in the Treatment of AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000725 - Completed
Sarcoma, Kaposi; HIV Infections
- Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin
ClinicalTrials.gov Identifier: NCT00491179 - Recruiting
Chronic Hepatitis C; Hemodialysis
- Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin for Treatment-naïve Dialysis Patients With Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00491244 - Recruiting
Chronic Hepatitis C; Hemodialysis
- Evaluation of the efficacy and safety of a high induction dose of Pegasys in combination with Copegus in patients with Chronic Hepatitis C who did not respond to previous treatment with PEG-Intron in combination with Rebetol/Ribavirin.
ClinicalTrials.gov Identifier: NCT00087646 - Active, not recruiting
Hepatitis
- Study of Viramidine to Ribavirin in Patients with Chronic Hepatitis C Who are Treatment Naive
ClinicalTrials.gov Identifier: NCT00093093 - Active, not recruiting
Chronic Hepatitis C
- Prevention of Disease Progress in Chronic Hepatitis C Patients with Liver Fibrosis
ClinicalTrials.gov Identifier: NCT00049842 - Active, not recruiting
Chronic Hepatitis C; Liver Fibrosis
- Peginterferon Alpha-2a Maintenance Therapy for Portal Hypertension in Patients With Hepatitis C
ClinicalTrials.gov Identifier: NCT00252642 - Completed
Hepatitis C; Cirrhosis; Fibrosis
- D.O.S.E. Registry
ClinicalTrials.gov Identifier: NCT00212862 - Active, not recruiting
Cancer; Anemia; Epoetin Alfa; Darbepoetin Alfa
- A Phase I/II Open Label Study To Evaluate the Antiviral Potential of Combination Low-Dose Therapy With Zidovudine and Interferon-Alpha 2A in Patients With Symptomatic HIV Disease
ClinicalTrials.gov Identifier: NCT00000696 - Completed
HIV Infections
- Darbepoetin Alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00046982 - Active, not recruiting
Fatigue; Anemia; unspecified adult solid tumor, protocol specific
- Treatment of Hepatitis in Patients who are Triple-Infected with HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)
ClinicalTrials.gov Identifier: NCT00051077 - Terminated
HIV Infections; Hepatitis B; Hepatitis C
- Addition of ISIS 14803 to Therapy with Peginterferon and Ribavirin for Chronic Hepatitis C (HCV) patients not Responding Adequately to the Two Drugs
ClinicalTrials.gov Identifier: NCT00062816 - Completed
Hepatitis C, Chronic
- Darbepoetin alfa Compared With Epoetin alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
ClinicalTrials.gov Identifier: NCT00070382 - Active, not recruiting
adult solid tumor; Anemia; Leukemia; Lymphoma; plasma cell neoplasm
- Interleukin-2 (IL-2), Pegylated Interferon (PEG-IFN alfa-2b), and Ribavirin (RBV) Treatment in Patients with Hepatitis C and HIV Coinfection
ClinicalTrials.gov Identifier: NCT00015652 - Completed
HIV Infections; Hepatitis C
- Hematologic Response of Epoetin Alfa (PROCRIT) Versus Darbepoetin Alfa (ARANESP) in Chemotherapy Induced Anemia
ClinicalTrials.gov Identifier: NCT00315484 - Active, not recruiting
Chemotherapy; Anemia
- A Study of AZT Plus Human Interferon Alpha in the Treatment of AIDS-Related Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00001113 - Completed
Sarcoma, Kaposi; HIV Infections
- Phase II Study of Zidovudine and Recombinant Alpha-2A Interferon in the Treatment of Patients With AIDS-Associated Kaposi's Sarcoma
ClinicalTrials.gov Identifier: NCT00000687 - Completed
Sarcoma, Kaposi; HIV Infections
- Peginterferon alpha-2b And Ribavirin to Treat Hepatitis C in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00018031 - Recruiting
Hepatitis C; HIV Infections
- Cost-Effectiveness Study of Epoetin Alfa and Darbepoetin Alfa in Adult Patients With Cancer Who Have Anemia
ClinicalTrials.gov Identifier: NCT00264108 - Recruiting
Neoplasms; Anemia
- Combination Chemotherapy Plus Interferon alfa or Rituximab in Treating Patients With Stage III or Stage IV Lymphoma
ClinicalTrials.gov Identifier: NCT00004039 - Active, not recruiting
Lymphoma
- Reduction of Immunosuppression Plus Interferon alfa and Combination Chemotherapy in Treating Patients With Malignant Tumors That Develop After Organ Transplant
ClinicalTrials.gov Identifier: NCT00002657 - Active, not recruiting
Lymphoma; Multiple Myeloma
- Interleukin-2 Plus Interferon Alfa in Treating Adults With Metastatic Cancer
ClinicalTrials.gov Identifier: NCT00002504 - Active, not recruiting
Lymphoma; Leukemia
- Interferon Alfa in Treating Children With HIV-Related Cancer
ClinicalTrials.gov Identifier: NCT00002621 - Active, not recruiting
Leukemia; Lymphoma
- Epoetin Alfa or Darbepoetin Alfa in Treating Patients With Anemia Caused by Chemotherapy
ClinicalTrials.gov Identifier: NCT00416624 - Recruiting
Anemia; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Unspecified Adult Solid Tumor, Protocol Specific
- Safety and Effectiveness of PEG-Intron in HIV-Infected Patients
ClinicalTrials.gov Identifier: NCT00005012 - Completed
HIV Infections
- Study of Nitazoxanide Combined With Peginterferon Compared to Peginterferon Monotherapy in the Treatment of Hepatitis C
ClinicalTrials.gov Identifier: NCT00418054 - Completed
Chronic Hepatitis C
- A Study to Evaluate the Combination of Pegylated Interferon Alfa Plus Valopicitabine in Patients with Hepatitis C
ClinicalTrials.gov Identifier: NCT00118768 - Active, not recruiting
Chronic Hepatitis C
- Phase 2a Randomized, Double-Blind Study of Oleoyl-Estrone in Male Morbidly Obese Adults
ClinicalTrials.gov Identifier: NCT00449254 - Active, not recruiting
Obesity
- Vaccine Therapy Compared With Interferon alfa in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00003715 - Active, not recruiting
stage III melanoma
- Interleukin-12 Followed by Interferon alfa in Treating Patients With Advanced Cancer
ClinicalTrials.gov Identifier: NCT00003451 - Active, not recruiting
Cancer
- Cisplatin, Interferon alfa, Surgery, and Radiation Therapy in Treating Patients With Malignant Pleural Mesothelioma
ClinicalTrials.gov Identifier: NCT00003263 - Active, not recruiting
localized malignant mesothelioma
- A Study of Subjects with Previously Untreated Extensive-Stage Small-Cell Lung Cancer (SCLC) Treated with Platinum Plus Etoposide Chemotherapy with Or Without Darbepoetin Alfa
ClinicalTrials.gov Identifier: NCT00119613 - Active, not recruiting
Small Cell Lung Cancer
- SU011248 versus Interferon-alfa as First-Line Systemic Therapy for Patients with Metastatic Renal Cell Carcinoma
ClinicalTrials.gov Identifier: NCT00083889 - Active, not recruiting
Renal Cell Carcinoma
- Interferon-alfa With or Without Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Newly Diagnosed Chronic Myelogenous Leukemia
ClinicalTrials.gov Identifier: NCT00002868 - Active, not recruiting
chronic phase chronic myelogenous leukemia
- Study of Nitazoxanide, Peginterferon, and Ribavirin Combination Therapies in the Treatment of Chronic Hepatitis C
ClinicalTrials.gov Identifier: NCT00421434 - Active, not recruiting
Chronic Hepatitis C
- Pegylated Interferon-Alpha-2a in Patients With Malignant Melanoma Stage IIA-IIIB
ClinicalTrials.gov Identifier: NCT00204529 - Active, not recruiting
Melanoma
- Phase 2a Obesity Study of Oral Doses of Oleoyl-Estrone (MP-101)
ClinicalTrials.gov Identifier: NCT00449202 - Active, not recruiting
Obesity
- Radiation Therapy With or Without Epoetin alfa in Treating Patients With Head and Neck Cancer
ClinicalTrials.gov Identifier: NCT00017277 - Active, not recruiting
Oral Cancer; Throat Cancer
- Interferon alfa in Treating Patients With Recurrent Unresectable Meningiomas and Malignant Meningiomas
ClinicalTrials.gov Identifier: NCT00002965 - Active, not recruiting
recurrent adult brain tumor
- Interferon alfa With or Without Vaccine Therapy in Treating Patients With Metastatic Melanoma
ClinicalTrials.gov Identifier: NCT00002767 - Active, not recruiting
Stage IV Melanoma; Recurrent Melanoma; Quality of Life
- A Study of Four Dosing Regimens of PROCRIT® (Epoetin Alfa) in Patients with Chronic Kidney Disease
ClinicalTrials.gov Identifier: NCT00212875 - Active, not recruiting
Kidney Diseases; Injections, Subcutaneous; Anemia
- Vaccine Therapy Plus Interleukin-2 With or Without Interferon alfa-2b in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00004104 - Active, not recruiting
stage III melanoma
- Interferon alfa Following Surgery in Treating Patients With Stage III Melanoma
ClinicalTrials.gov Identifier: NCT00006249 - Active, not recruiting
stage III melanoma
- Interferon alfa-2b With or Without Radiation Therapy in Treating Patients With Melanoma That Has Metastasized to Lymph Nodes in the Neck, Under the Arm, or in the Groin
ClinicalTrials.gov Identifier: NCT00003444 - Active, not recruiting
Stage IV Melanoma; stage III melanoma; Recurrent Melanoma
- Epoetin Alfa in Treating Fatigue in Patients With Advanced Solid Tumors Who Are Not Receiving Chemotherapy
ClinicalTrials.gov Identifier: NCT00052221 - Active, not recruiting
unspecified adult solid tumor, protocol specific; Fatigue
Resources
- Pegasys (Drug Digest)
- Peginterferon alfa-2a (Drug Digest)
email this page
print this page
bookmark this page
feedback on this page
